SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Samuel Johnson

PatientSamuel Johnson
Date of birth1970-09-18
IdentifiersMRN HR-EN008-SYN; SSN (made up) 000-08-7139
Document date2026-05-18
AuthorCatriona Bell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week depression review. [S]

History of Present Illness

Mr. Johnson returns six weeks after starting sertraline 50 mg. He is a little better: he has written letters, though not his book, and walked out with a friend twice. He still wakes in the early morning with dread and reproaches himself for idleness. He has had five psychotherapy sessions and the first two sessions of behavioral therapy for tics, in which he is learning to notice the urge before the head-shaking tic and to answer it with a competing movement. He has no side effects. [S]

ElementDetail
Sertraline50 mg daily for six weeks
MoodPHQ-9 15; GAD-7 9
PsychotherapyFive sessions
Tic therapyTwo sessions
Side effectsNone

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo weight change or sweats
NeurologicalPositiveTics as before
PsychiatricPositiveMood a little better; early waking; no thoughts of suicide or self-harm

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-04-06 to 2026-05-18completedS
Sertraline 100 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-05-18Body height183cmS
2026-05-18Body weight98.2kgS
2026-05-18Body mass index (BMI) [Ratio]29.3kg/m2S
2026-05-18Systolic blood pressure124mm[Hg]S
2026-05-18Diastolic blood pressure78mm[Hg]S
2026-05-18Heart rate78/minS
2026-05-18Respiratory rate14/minS
2026-05-18Body temperature36.7CelS
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]15{score}S
2026-05-18Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S

Physical Exam

Vital signs recorded on 2026-05-18; see the Vital Signs section. [S]

SystemFinding
GeneralBetter groomed; blood pressure 124/78, pulse 78
NeurologicalTics as described at the consultation
PsychiatricLess slowed; reactive affect

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholyactiveconfirmed F33.2S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health.
Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requestedresolvedconfirmed F95.9S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation.
Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosisactiveconfirmed F95.2S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact.
Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eyeactiveconfirmed H54.42S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyDepression measure (PHQ-9)At baseline and at least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today15, from 21: partial response
Medication safetySertraline adherence and adverse effectsEvery visit in the acute phase; reassess at 2 weeks after starting and after each dose changeCompleted todayNo side effects; increased to 100 mg
SurveySuicide-risk review (PHQ-9 item 9 and structured questions since the last visit), safety plan, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm
ReferralPsychotherapy (cognitive behavioral therapy with behavioral activation)Offer to all with moderate or severe depressionCompleted todayFive sessions
SurveyAnxiety measure (GAD-7)At baseline and with PHQ-9 reviewsCompleted today9, from 12
SurveyTic severity (Yale Global Tic Severity Scale, recorded in the note; no LOINC code is used)At diagnosis and periodically to judge the need for and response to treatmentDueAt three months
ReferralComprehensive Behavioral Intervention for TicsOffer as an initial treatment optionCompleted todayTwo of eight sessions
Medication safetyTic-suppressing medication (alpha-2 agonist, aripiprazole, or other)When tics cause impairment that behavioral therapy does not relieveNot indicatedNot needed

Goal progress:

Guideline basis: Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders (Pringsheim T, et al. Neurology 2019;92(19):896-906) (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Review in five weeks. Psychotherapy weekly; tic therapy weekly. Next scheduled visit 2026-06-22: eleven-week review of depression and tics. [S]